Editorial

Caring for Mind and Heart

Abstract

No Abstract No Abstract No Abstract No Abstract

[1] Lally, J. and J.H. MacCabe, Antipsychotic medication in schizophrenia: a review. Br Med Bull, 2015. 114(1): p. 169-79.
[2] Meltzer, H.Y., Update on typical and atypical antipsychotic drugs. Annu Rev Med, 2013. 64: p. 393-406.
[3] De Hert, M., et al., Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol, 2011. 8(2): p. 114-26.
[4] Foley, D.L. and K.I. Morley, Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry, 2011. 68(6): p. 609-16.
[5] Edinoff, A.N., et al., Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review. Neurol Int, 2022. 14(1): p. 294-309.
[6] Patterson Daniel, K.M.R., Luna Rudy, Sadeque Jafor, Sakshi Prasad, Chaithanya Avanthika, and Sharan Jhaverig, Myocarditis in patients on long-term antipsychotics –mechanism, management and recent updates. 2023.
[7] Beach, S.R., et al., QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics, 2018. 59(2): p. 105-122.
Files
IssueVol 8 No 2 (2023): March-April QRcode
SectionEditorial
DOI https://doi.org/10.18502/crcp.v8i2.14086
Keywords
No Keywords No Keyword

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Akhondzadeh S, FarahMand Y. Caring for Mind and Heart. CRCP. 2023;8(2):50-51.